中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [27]
上海生物化学与细胞... [13]
上海营养与健康研究所 [6]
深圳先进技术研究院 [5]
昆明动物研究所 [4]
金属研究所 [3]
更多
采集方式
OAI收割 [83]
iSwitch采集 [3]
内容类型
期刊论文 [80]
学位论文 [4]
会议论文 [2]
发表日期
2023 [1]
2022 [3]
2021 [4]
2020 [4]
2019 [4]
2018 [13]
更多
学科主题
Biochemist... [5]
Cell Biolo... [4]
生物化学与分子生物学 [3]
Biochemist... [2]
Endocrinol... [2]
Science & ... [2]
更多
筛选
浏览/检索结果:
共86条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Porphyra haitanensis Polysaccharides Attenuates Blood Lipid via Gut-Liver Axis in Diet-Induced High-Fat Mesocricetus auratus through Multiple Integrated Omics
期刊论文
OAI收割
MOLECULAR NUTRITION & FOOD RESEARCH, 2023, 页码: 15
作者:
Zeng, Hongliang
;
Chen, Peilin
;
Wang, Zhiyun
;
Hu, Xiaoke
;
Zhang, Yi
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/07/18
gut microbiota
gut-liver axis
hyperlipidemia
lipomics
Porphyra haitanensis polysaccharide
transcriptomics
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
期刊论文
OAI收割
CANCER COMMUNICATIONS, 2022
作者:
Wu, Huanwen
;
Yu, Zicheng
;
Liu, Yueping
;
Guo, Lei
;
Teng, Lianghong
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2022/12/22
Neuroendocrine carcinomas
Gastrointestinal tract
Genomic characterization
Heterogeneity
Therapeutic implications
Glycine-beta-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice
期刊论文
OAI收割
HEPATOLOGY COMMUNICATIONS, 2022, 页码: 16
作者:
Jiang, Jie
;
Ma, Yuandi
;
Liu, Yameng
;
Lu, Dasheng
;
Gao, Xiaoxia
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/11/11
Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 卷号: 18, 期号: 4, 页码: 1594-1611
作者:
Li, Qian
;
Tan, Jia-Xin
;
He, Yong
;
Bai, Fang
;
Li, Shi-Wei
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/06/15
ATL III
AdipoR1
oxidative stress
inflammation
AMPK
SIRT1
Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9
期刊论文
OAI收割
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 卷号: 22, 期号: 6, 页码: 9
作者:
Li, Huihui
;
Li, Jun
;
Zhang, Xianjing
;
Li, Jiaomeng
;
Xi, Cong
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/06/15
euphornin L
lipid-lowering activity
low density lipoprotein receptor
proprotein convertase subtilisin
kexin type 9
extracellular signal-regulated kinase protein
secretion
Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness
期刊论文
OAI收割
CANCER RESEARCH, 2021, 卷号: 81, 期号: 22, 页码: 5720-5732
作者:
Yang, Lin
;
Sun, Jingya
;
Li, Meiqian
;
Long, Yiming
;
Zhang, Dianzheng
  |  
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/01/04
Transcriptomic and metabonomic analyses reveal roles of VPS 29 in carotenoid accumulation in adductor muscles of QN Orange scallops
期刊论文
OAI收割
GENOMICS, 2021, 卷号: 113, 期号: 4, 页码: 2839-2846
作者:
Song, Junlin
;
Wang, Chunde
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2021/10/21
Transcriptomic
VPS29
Carotenoid deposition
mRNA
Biomimetic camouflage delivery strategies for cancer therapy
期刊论文
OAI收割
NANOSCALE, 2021, 页码: 14
作者:
Asrorov, Akmal M.
;
Gu, Zeyun
;
Li, Feng
;
Liu, Lingyun
;
Huang, Yongzhuo
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2021/06/11
Dual-targeting and excretable ultrasmall SPIONs for T-1-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein
期刊论文
OAI收割
JOURNAL OF MATERIALS CHEMISTRY B, 2020, 期号: 11, 页码: 2296
作者:
Du, CJ
;
Liu, XP
;
Hu, H
;
Li, HM
;
Yu, LD
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/12/23
23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 3, 页码: 327-335
作者:
Li, Hui-hui
;
Li, Jun
;
Zhang, Xian-jing
;
Li, Jiao-meng
;
Xi, Cong
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/07/01
23,24-dihydrocucurbitacin B
lipid-lowering agent
LDLR
PCSK9
HNF1 alpha
SREBP2